GGrantIndex
Sort

141,003 grants matching cytokine

Antiviral and immunomodulatory effects of interferon lambda in the skin

$594,722
Helen Lazear · Univ Of North Carolina Chapel Hill · R01 · FY2023 · AI

Antiviral and immunomodulatory effects of interferon lambda in the skin

$594,722
Helen Lazear · Univ Of North Carolina Chapel Hill · R01 · FY2025 · AI

Modified Cotton Dressing for Treating Chronic Wounds

$594,709
Tissue Technologies Holding, Llc · R44 · FY2004 · GM

Genetically-engineered Bacteria Overcome Therapy Resistance

$594,699
Ralph R Weichselbaum · University Of Chicago · R01 · FY2025 · CA

Incorporating Nutrition, Vests, Education, and Strength Training in Bone Health (INVEST in Bone Health)

$594,694
Kristen Marie Beavers · Wake Forest University · R01 · FY2020 · AG

GINGIVA DERIVED MSCS: ROLE IN IMMUNOMODULATION AND TISSUE REGENERATION

$594,677
Anh D Le · University Of Southern California · R01 · FY2009 · DE

IL-33 Blockade as a Novel Therapeutic for T-cell Mediated Hypercytokinemia Syndromes

$594,670
Edward M Behrens · Children'S Hosp Of Philadelphia · R01 · FY2018 · AI

Core--Laboratory and Data Management

$594,659
Ernst John Schaefer · Beth Israel Deaconess Medical Center · P50 · FY2012 · HL

Effects of vitamin D and Omega-3 supplementation on telomeres in VITAL

$594,658
Yanbin Dong · Augusta University · R01 · FY2018 · HL

Effects of vitamin D and Omega-3 supplementation on telomeres in VITAL

$594,658
Yanbin Dong · Augusta University · R01 · FY2019 · HL

Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome

$594,601
Gary Andrew Weisman · University Of Missouri-Columbia · R01 · FY2025 · DE

Targeting P2 Receptors to Restore Salivary and Lacrimal Gland Function in Sjogren's Syndrome

$594,601
Gary Andrew Weisman · University Of Missouri-Columbia · R01 · FY2023 · DE

Renal Denervation to Treat Polycystic Kidney Disease: Mechanisms and Mediators

$594,574
Christopher T Banek · University Of Minnesota · R01 · FY2025 · DK

Chronic respiratory effects of early life PM exposure

$594,558
Kirk R Smith · University Of California Berkeley · R01 · FY2006 · ES

Instructive role of MLL fusion proteins in lineage determination and leukemogenesis

$594,545
Michael J Thirman · University Of Chicago · R01 · FY2021 · CA

Instructive role of MLL fusion proteins in lineage determination and leukemogenesis

$594,545
Michael J Thirman · University Of Chicago · R01 · FY2020 · CA

Engineered polymeric adjuvants for heart-redirected targeting and gene therapy

$594,531
Andrei Maiseyeu · Case Western Reserve University · R01 · FY2025 · HL

Characterization of an endogenous GABA-ergic mechanism underlying hypersomnia

$594,531
David B Rye · Emory University · R01 · FY2016 · NS

Metabolism and HCMV: determinants of the antiviral state

$594,525
Joshua C Munger · University Of Rochester · R01 · FY2025 · AI

DEVELOPMENT OF ANTICO RECEPTOR MABS FOR HIV THERAPY

$594,521
Progenics Pharmaceuticals, Inc. · R44 · FY2000 · AI

Allosteric modulation of beta2- adrenoceptors in the treatment of asthma

$594,516
Deepak A Deshpande · Thomas Jefferson University · R01 · FY2024 · HL

Studies of Retinopathy of AIDS in the HAART Era

$594,502
William R. Freeman · University Of California, San Diego · R01 · FY2009 · EY

Targeting Inflammation with Salsalate as a Novel Therapy for Diabetic Neuropathy

$594,488
Eva L Feldman · University Of Michigan At Ann Arbor · R01 · FY2016 · DK

Transcriptomic, Oxidative Stress, and Inflammatory Responses to Air Pollutants

$594,408
Ralph J Delfino · University Of California-Irvine · R01 · FY2014 · ES

Rational targeting of Cdc42 to benefit immunotherapy

$594,402
Yi Zheng · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · CA